Daily Dose: Long-COVID Rehabilitation Interventions
Your daily dose of the clinical news you may have missed.
New COVID-19 Monovalent Vaccine Could Face Resistance, KFF Poll Finds
Less than one-quarter of US adults surveyed said they would "definitely" get the shot while 33% stated they would "definitely not" get the new vaccine.
A Pediatric Rehabilitation Physician's View on Poverty as Cause and Consequence of Disability
Amy Houtrow, MD, PhD, MPH, considers the impact of poverty on childhood disability and talks about opportunities to breach barriers to health care access.
Adding 3000 Ordinary Steps/Day Reduced BP in Sedentary Older Adults with Hypertension
An e-health lifestyle walking intervention partially supported by remote coaching led to significant improvement in BP in older adults as well as a desire to keep walking.
Investigational Nasal Spray Found Safe, Effective for Self-Treatment of Paroxysmal Supraventricular Tachycardia
Etripamil 70 mg nasal spray restored heart rate within 30 minutes in approximately 60% of PSVT episodes, report authors of new study.
10 Questions on Adult Blood Pressure Targets Based on AAFP Guidelines
The 2022 AAFP Clinical Practice Guideline on hypertension treatment in adults is the subject matter for this 10-question topline quiz that is also a good source of review.
Daily Dose: Fatigue More Common in Chronic vs Episodic Migraine
Oral vs Transdermal Hormone Therapy after Menopause Linked to Increased Risk of NAFLD
Among postmenopausal women taking hormones orally, the NAFLD prevalence increased from 25.3 to 29.4% while it decreased from 24 to 17.3% in those using the transdermal route.
Children with Disabilities Can Grow, Thrive, and Be Part of their Communities: Expert Perspective
Renowned pediatric rehabilitation physician Amy Houtrow, MD, PhD, MPH, highlights the scope of the specialty and its core objectives.
Pegozafermin Receives Breakthrough Therapy Designation for Nonalcoholic Steatohepatitis
The US Food and Drug Administration granted BTD to pegozafermin for the treatment of patients with NASH.
Daily Dose: Dupilumab Potent Against Uncontrolled COPD with Type 2 Inflammation
GLP-1 Mimetics, SGLT-2 Inhibitors Understudied in Black Populations in Pivotal Trials, Benefits Questioned
Pivotal cardiovascular outcome trials that evaluated cardiorenal benefits of the newer classes were not designed to consider racial/ethnic variations, researchers state.
Physiatry to Primary Care: Think Outside the Box—Call Us
How can a nearby physiatrist help your patient with hypertension? If comorbid arthritis has the person couchbound, a consult and some PT could go a long way.
ACIP Recommends Maternal RSV Vaccine to Protect Newborns
Members of the ACIP voted on Friday to recommend Pfizer’s maternal bivalent RSVpreF vaccine to protect newborns from severe RSV illness.
Daily Dose: Early Childhood Obesity Treatment Found Effective Long-Term
Biosimilar Liraglutide Noninferior to Reference Product in Persons with Type 2 Diabetes: Phase 3 Trial
The biosimilar to the GLP-1 mimetic Victoza proved noninferior for reduction of HbA1c and had similar positive effects on body weight, lipids, and blood pressure.
That Patient with Neck Pain in Exam Rm 2 May not Need a Neurology Referral Today
The patient with neck pain might be better off referred to a physiatrist for additional evaluation and possibly treatment, according to PM&R physician Atul Patel, MD.
Empagliflozin Wins FDA Approval for the Treatment of Adults with CKD
Empagliflozin is approved to lower the risk of sustained decline in eGFR, end-stage kidney disease, CV death, and hospitalization in adults with CKD at risk of progression.
Daily Dose: Antihypertensive Treatment Throughout Late Life Lowers Risk of Dementia
Waist-to-Hip Ratio More Consistently Associated with Mortality vs BMI: New Research
Waist-to-hip ratio was more powerfully and consistently associated with risk of all-cause mortality than BMI or FMI, but can it replace BMI as a clinical indicator?
